UREAS DIFENILICIAS X-CARBOXIARIL SUSTITUIDAS COMO INHIBIDORES DE RAF QUINASA

LA PRESENTE INVENCIÓN SE REFIERE AL USO DE ARILUREAS DE FORMULA GENERAL: A-D-B O UNA SAL FARMACÉUTICAMENTE ACEPTABLE DONDE A, D Y B SON COMPUESTOS DE ESTRUCTURAS DESCRITAS EN EL EXPEDIENTE. This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutic...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	TIMOTHY LOWINGER, JAQUES DUMAS, UDAY KHIRE, ROGER A. SMITH, MARY-KATHERINE MONAHAN, REINA NATERO, BERN RIEDL, JILL. E. WOOD
Format:	Patent
Sprache:	spa
Schlagworte:	ACYCLIC OR CARBOCYCLIC COMPOUNDS ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	LA PRESENTE INVENCIÓN SE REFIERE AL USO DE ARILUREAS DE FORMULA GENERAL: A-D-B O UNA SAL FARMACÉUTICAMENTE ACEPTABLE DONDE A, D Y B SON COMPUESTOS DE ESTRUCTURAS DESCRITAS EN EL EXPEDIENTE. This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.